{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:03:29Z","timestamp":1777982609079,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["R01 DK067859"],"award-info":[{"award-number":["R01 DK067859"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007397","name":"Univerzita Karlova v Praze","doi-asserted-by":"publisher","award":["RVO-VFN64165"],"award-info":[{"award-number":["RVO-VFN64165"]}],"id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["PRVOUK-P24\/LF1\/3"],"award-info":[{"award-number":["PRVOUK-P24\/LF1\/3"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["19509"],"award-info":[{"award-number":["19509"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.cca.2013.06.027","type":"journal-article","created":{"date-parts":[[2013,7,6]],"date-time":"2013-07-06T17:31:33Z","timestamp":1373131893000},"page":"153-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy"],"prefix":"10.1016","volume":"425","author":[{"given":"Ladislav","family":"Kucha\u0159","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Befekadu","family":"Asfaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Poup\u011btov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Honz\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franti\u0161ek","family":"Ture\u010dek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Ledvinov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.06.027_bb0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3371","article-title":"Sphingolipid activator proteins","author":"Sandhoff","year":"2001"},{"key":"10.1016\/j.cca.2013.06.027_bb0010","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3695","article-title":"Metachromatic leukodystrophy","author":"von Figura","year":"2001"},{"key":"10.1016\/j.cca.2013.06.027_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2011.10.002","article-title":"Developing treatment options for metachromatic leukodystrophy","volume":"105","author":"Batzios","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2013.06.027_bb0020","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/bmt.2008.275","article-title":"Metachromatic leukodystrophy: an overview of current and prospective treatments","volume":"42","author":"Biffi","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cca.2013.06.027_bb0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/mt.2008.305","article-title":"Enzyme replacement improves ataxic gait and central nervous system histopathology in a mouse model of metachromatic leukodystrophy","volume":"17","author":"Matzner","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cca.2013.06.027_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10545-007-0540-z","article-title":"Enzyme, cell and gene-based therapies for metachromatic leukodystrophy","volume":"30","author":"Sevin","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.cca.2013.06.027_bb0035","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/hmg\/ddr175","article-title":"Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy","volume":"20","author":"Stroobants","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2013.06.027_bb0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0009-8981(59)90119-6","article-title":"The assay of arylsulphatases A and B in human urine","volume":"4","author":"Baum","year":"1959","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.06.027_bb0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0009-8981(77)90172-3","article-title":"A sensitive fluorescence assay for the simultaneous and separate determination of arylsulphatases A and B","volume":"79","author":"Christomanou","year":"1977","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.06.027_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0009-8981(87)90068-4","article-title":"A simple chromogenic assay for arylsulfatase A","volume":"164","author":"Lee-Vaupel","year":"1987","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.06.027_bb0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0076-6879(87)38063-2","article-title":"Enzymatic diagnosis of sphingolipidoses","volume":"138","author":"Suzuki","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.cca.2013.06.027_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00288270","article-title":"Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications","volume":"82","author":"Hohenschutz","year":"1989","journal-title":"Hum Genet"},{"key":"10.1016\/j.cca.2013.06.027_bb0065","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.86.23.9436","article-title":"Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site","volume":"86","author":"Gieselmann","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.06.027_bb0070","first-page":"191","article-title":"Very low arylsulfatase A and cerebroside sulfatase activities in leukocytes of healthy members of metachromatic leukodystrophy family","volume":"29","author":"Dubois","year":"1977","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cca.2013.06.027_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00286589","article-title":"Arylsulfatase A in pseudodeficiency","volume":"66","author":"Herz","year":"1984","journal-title":"Hum Genet"},{"key":"10.1016\/j.cca.2013.06.027_bb0080","doi-asserted-by":"crossref","first-page":"7323","DOI":"10.1073\/pnas.80.23.7323","article-title":"Pseudo arylsulfatase-A deficiency in healthy individuals: genetic and biochemical relationship to metachromatic leukodystrophy","volume":"80","author":"Chang","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.06.027_bb0085","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1203\/00006450-198003000-00009","article-title":"Prenatal diagnosis of metachromatic leukodystrophy in a family with pseudo arylsulfatase A deficiency by the cerebroside sulfate loading test","volume":"14","author":"Kihara","year":"1980","journal-title":"Pediatr Res"},{"key":"10.1016\/j.cca.2013.06.027_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/15.7.421","article-title":"Dichroism of cresyl violet-stained cerebroside sulfate (\"sulfatide\")","volume":"15","author":"Dayan","year":"1967","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.cca.2013.06.027_bb0095","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.151.3715.1231","article-title":"Metachromatic leucodystrophy: isolation and chemical analysis of metachromatic granules","volume":"151","author":"Suzuki","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.cca.2013.06.027_bb0100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0022-2275(20)39492-X","article-title":"Human urinary sulfatides in patients with sulfatidosis (metachromatic leukodystrophy)","volume":"12","author":"Philippart","year":"1971","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.06.027_bb0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/abio.1999.4002","article-title":"Determination of urinary sulfatides and other lipids by combination of reversed-phase and thin-layer chromatographies","volume":"269","author":"Berna","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2013.06.027_bb0110","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/clinchem\/42.2.232","article-title":"Urine sulfatides and the diagnosis of metachromatic leukodystrophy","volume":"42","author":"Natowicz","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.06.027_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/abio.1999.4245","article-title":"A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction","volume":"274","author":"Sugiyama","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2013.06.027_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ymgme.2009.09.006","article-title":"Biochemical profiling to predict disease severity in metachromatic leukodystrophy","volume":"99","author":"Tan","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.06.027_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1006\/mgme.2001.3165","article-title":"Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry","volume":"73","author":"Whitfield","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.06.027_bb0130","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1194\/jlr.M500188-JLR200","article-title":"A novel mass spectrometric assay for the cerebroside sulfate activator protein (saposin B) and arylsulfatase A","volume":"46","author":"Norris","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2013.06.027_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ajmg.a.32712","article-title":"Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations","volume":"149A","author":"Kuchar","year":"2009","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.cca.2013.06.027_bb0140","series-title":"Metabolomics, metabonomics and metabolite profiling","first-page":"116","article-title":"Phospholipid profiling","author":"Postle","year":"2008"},{"key":"10.1016\/j.cca.2013.06.027_bb0145","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/rcm.4659","article-title":"Semisynthesis of C17:0 isoforms of sulphatide and glucosylceramide using immobilised sphingolipid ceramide N-deacylase for application in analytical mass spectrometry","volume":"24","author":"Kuchar","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.cca.2013.06.027_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2013.06.027_bb0155","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.cca.2010.08.014","article-title":"Flow injection analysis vs. ultra high performance liquid chromatography coupled with tandem mass spectrometry for determination of imatinib in human plasma","volume":"411","author":"Micova","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2013.06.027_bb0160","series-title":"Food and Drug Administration","article-title":"FDA guidance for industry: bioanalytical method validation: US Department of Health and Human Services","author":"Rockville","year":"2001"},{"key":"10.1016\/j.cca.2013.06.027_bb0165","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation","volume":"10","author":"Hulkova","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cca.2013.06.027_bb0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0005-2760(88)90116-6","article-title":"Region-specific distribution of glycosphingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid","volume":"961","author":"Natomi","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2013.06.027_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-59745-255-7_10","article-title":"Tandem mass spectrometry in the detection of inborn errors of metabolism for newborn screening","volume":"359","author":"Turecek","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cca.2013.06.027_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.ajkd.2010.10.046","article-title":"Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study","volume":"57","author":"Paschke","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cca.2013.06.027_bb0185","doi-asserted-by":"crossref","first-page":"30022","DOI":"10.1074\/jbc.M111.261206","article-title":"Encephalopathy caused by ablation of very long acyl chain ceramide synthesis may be largely due to reduced galactosylceramide levels","volume":"286","author":"Ben-David","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.06.027_bb0190","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.1074\/jbc.M707386200","article-title":"Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate","volume":"283","author":"Laviad","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2013.06.027_bb0195","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1021\/ac302748b","article-title":"Normalizing and integrating metabolomics data","volume":"84","author":"De Livera","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.cca.2013.06.027_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ymgme.2009.01.011","article-title":"Falsely elevated urinary Gb3 (globotriaosylceramide, CTH, GL3)","volume":"97","author":"Forni","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.06.027_bb0205","series-title":"Tandem mass spectrometry \u2014 applications and principles","first-page":"739","article-title":"Tandem mass spectrometry of sphingolipids: application in metabolic studies and diagnosis of inherited disorders of sphingolipid metabolism","author":"Kuchar","year":"2012"},{"key":"10.1016\/j.cca.2013.06.027_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/ajcp\/82.1.24","article-title":"Immunohistochemical localization of glycosphingolipid in urinary renal tubular cells in Fabry's disease","volume":"82","author":"Chatterjee","year":"1984","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cca.2013.06.027_bb0215","series-title":"Fabry Disease","first-page":"211","article-title":"Renal manifestation of Fabry disease","author":"Warnock","year":"2010"},{"key":"10.1016\/j.cca.2013.06.027_bb0220","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/clinchem\/21.6.725","article-title":"Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography","volume":"21","author":"Iwamori","year":"1975","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2013.06.027_bb0225","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1399-0004.1986.tb00505.x","article-title":"Evaluation of urinary cells in acid cholesteryl ester hydrolase deficiency","volume":"29","author":"Chatterjee","year":"1986","journal-title":"Clin Genet"},{"key":"10.1016\/j.cca.2013.06.027_bb0230","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/dc.20139","article-title":"Repair renal tubular cells: a potential false-positive diagnosis in urine cytology","volume":"31","author":"Nguyen","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cca.2013.06.027_bb0235","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/iub.319","article-title":"Mammalian ceramide synthases","volume":"62","author":"Levy","year":"2010","journal-title":"IUBMB Life"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:01:22Z","timestamp":1762113682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"alternative-id":["S0009898113002684"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.06.027","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}